Cost of COVID-19 Mass Vaccination in Yogyakarta Health Center Level: A Case Study
Abstract
The Corona Virus Disease-19 (COVID-19) outbreak had a significant impact on every sector. To minimize the case and the mortality rate, the vaccination program is accelerated using every possible strategy. One of the strategies employed in Indonesia is the mass vaccination program. This study aimed to estimate the unit cost of the mass vaccination program service delivery of COVID-19 Sinovac vaccine per dose and per fully vaccinated (2-dose) against COVID-19 in a public health center facility in Yogyakarta city. The costing study used activity-based cost according to the financial data, interviews, and direct observations. The incremental financial cost and full economic cost were calculated using the government or provider's point of view. The total cost is then divided by the number of doses injected and multiplied by two to get the cost per fully vaccinated person. The incremental financial cost and economic values per dose were USD32.64 and USD33.57, while for the fully vaccinated person (2-dose) using Sinovac Vaccine were USD 65.28 and USD 67.15, respectively. Based on the one-way sensitivity analysis, the unit cost per fully vaccinated is influenced by vaccine price and the number of vaccinated people per mass vaccination session.
References
BPS-Statistic of Yogyakarta Municipality. (2020). Ngampilan Sub Distrit in Figure. Yogyakarta. Retrieved from https://jogjakota.bps.go.id/publication
Center for Disease Control and Prevention Ministry of Health Republic of Indonesia. Petunjuk Teknis Pelaksanaan Vaksinasi dalam Rangka Penanggulangan Pandemi Corona Virus Disease 2019 (COVID-19) (2021). Indonesia. Retrieved from https://www.kemkes.go.id/article/view/19093000001/penyakit-jantung-penyebab-kematian-terbanyak-ke-2-di-indonesia.html
Grabenstein, J. D., & Nevin, R. L. (2006). Mass Immunization Programs: Principles and Standards. Current Topics in Microbiology and Immunology, 304, 31–51. https://doi.org/10.1007/3-540-36583-4_3/COVER
Griffiths, U., Adjagba, A., Attaran, M., Hutubessy, R., Van De Maele, N., Yeung, K., … Bank, W. (2021). Costs of delivering COVID-19 Vaccine in 92 AMC Countries Updated Estimates from COVAX Working Group on Delivery costs 8 th February 2021. Retrieved from https://www.who.int/publications/i/item/10665337553
Indonesia Central Bureau of Statistics. (2021). Index 2018. Retrieved from https://www.bps.go.id/
Ma, A., Juniarti N, & Yamin A. (2021). The Roles of Community Health Nurses’ in Covid-19 Management in Indonesia: A Qualitative Study. IJCBNM, 1–14. https://doi.org/10.30476/IJCBNM.2021.90884.1739
Ministry of Health Republic of Indonesia. Roadmap of COVID-19 Implementation at National Level - V.01. (2021).
Ministry of Health Republic of Indonesia. (2021b). Vaksin Dashboard. Retrieved August 17, 2021, from https://vaksin.kemkes.go.id/#/vaccines
Moi, F., Banks, C., & Boonstoppel, L. (2020). The Cost of Routine Immunization Outreach in the Context of COVID-19: Estimates from Tanzania and Indonesia. Thinkwell Global.
Ophinni, Y., Hasibuan, A. S., Widhani, A., Maria, S., Koesnoe, S., Yunihastuti, E., … Djauzi, S. (2020). COVID-19 Vaccines: Current Status and Implication for Use in Indonesia. Acta Medica Indonesiana, 52(4), 388. Retrieved from https://actamedindones.org/index.php/ijim/article/view/1648
Satuan Tugas Penanganan COVID-19. (2021). Situasi COVID-19 Nasional. Retrieved July 13, 2021, from https://covid19.go.id/id/situasi
World Health Organization. (2020). Framework for Decision-Making: Implementation of Mass Vaccination Campaigns in the Context of COVID-19. Retrieved October 15, 2022, from https://www.who.int/publications/i/item/WHO-2019-nCoV-Framework_Mass_Vaccination-2020.1
